PALVELLA THERAPEUTICS INC (PVLA) Earnings History & Surprises

NASDAQ:PVLAUS6979471090

Current stock price

112.37 USD
-5.24 (-4.46%)
At close:
112.4 USD
+0.03 (+0.03%)
After Hours:

PVLA Earnings overview

Past quarterly earnings results for PALVELLA THERAPEUTICS INC (PVLA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Mar 31, 2026
Period
Q4 / 2025
EPS Estimate
-$0.93
Revenue Estimate

Last Reported

Most Recent
Release Date
Nov 11, 2025
Period
Q3 / 2025
EPS Reported
-$1.03
EPS Surprise
-20.45%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2025 -1.03 -0.86 -20.45% -1,919.61% - -
Q2 2025 -0.86 -0.76 -13.81% -2,710.46% - -
Q1 2025 -0.74 -1.24 40.10% -1,109.15% - -100.00%
Q4 2024 -2.72 -0.66 -313.44% -2,122.22% - -100.00%
Q3 2024 -0.05 - -101.59% 1.09M -100.00% -100.00%
Q2 2024 -0.03 - -100.76% 2.289M -100.00% -100.00%
Q1 2024 -0.06 - 99.58% 53K 2.289M -97.68% -97.26%
Q4 2023 -0.12 - 98.61% 1.299M 2.289M -43.25% -77.78%
Q3 2023 3.20 -8.98 135.65% 130.77% 19.52M 7.899M 147.12% 263.50%
Q2 2023 4.00 -13.06 130.64% 135.71% 20.055M 4.099M 389.27% 442.32%
Q1 2023 -14.40 -11.42 -26.05% -157.14% 1.936M 6.636M -70.83% -82.38%
Q4 2022 -8.80 -18.77 53.11% 16.76% 5.846M 6.641M -11.97% -30.76%
Q3 2022 -10.40 -13.06 20.34% 45.83% 5.37M 2.301M 133.38% 32.36%
Q2 2022 -11.20 -8.98 -24.78% 44.00% 3.698M 10.68M -65.37% 12.57%
Q1 2022 -5.60 -9.38 40.32% - 10.988M 11.53M -4.70% -29.71%
Q4 2021 -10.57 -24.48 56.81% 49.17% 8.443M 2.503M 237.32% 349.81%
Q3 2021 -19.20 -19.86 3.30% 7.69% 4.057M 5.423M -25.19% 38.04%
Q2 2021 -20.00 -21.62 7.51% -177.78% 3.285M 2.117M 55.17% -70.79%
Q1 2021 -5.60 -13.87 59.63% - 15.633M 6.596M 137.01% 17.89%
Q4 2020 -20.80 -19.31 -7.70% - 1.877M 3.893M -51.79% -
Q3 2020 -20.80 -10.62 -95.78% - 2.939M 9.99M -70.58% -
Q2 2020 -7.20 -14.00 48.58% - 11.246M 7.918M 42.03% -
Q1 2020 -5.60 -13.55 58.66% - 13.261M 9.017M 47.07% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

PVLA EPS Q2Q GrowthPVLA EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 0 -500 -1K -1.5K -2K -2.5K

Revenue Historical Q2Q growth and Acceleration

PVLA Revenue Q2Q GrowthPVLA Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q4/27 0 20K 40K 60K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
1
Average EPS beat (4)
-76.90%
Max EPS beat (4)
40.10%
Min EPS beat (4)
-313.44%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, PVLA has beaten EPS estimates in 1 out of 4 releases
In the last 4 quarters, PVLA reported -76.9% below the EPS estimates on average.

PALVELLA THERAPEUTICS INC / PVLA Earnings FAQ

When did PALVELLA THERAPEUTICS INC (PVLA) report earnings last quarter?

PALVELLA THERAPEUTICS INC (PVLA) last reported earnings on 11/11/2025.

Did PVLA stock beat earnings estimates in the most recent quarter?

PALVELLA THERAPEUTICS INC (PVLA) missed EPS estimates and missed revenue estimates in the most recent quarter.

How often does PALVELLA THERAPEUTICS INC (PVLA) beat earnings estimates?

In the last 4 quarters, PALVELLA THERAPEUTICS INC (PVLA) has beaten EPS estimates in 1 out of 4 releases.